WIRE — Kampala, Uganda | URN | Scientists are exploring the possibility of having the popular HIV prevention injection Lenacapavir in a formulation dispensed once a year. The drug, first approved in 2025 and whose uptake is reported to be high in Uganda as a twice-yearly Pre-Exposure Prophylaxis (PrEP), according to Senior Researcher Dr Flavia Matovu Kiweewa, … The post Scientists study yearly HIV prevention injection possibility appeared first on The Independent Uganda:.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.